Latest Benzodiazepines Stories

Diazepam Addiction Treatment and Drug Rehab Announced by Recovery Associates, Offering Treatment for Those Addicted to Diazepam. WEST PALM BEACH, Fla. (PRWEB) May 21, 2013 Recovery Associates, through its multiple therapeutic tracks, is placing an emphasis upon Diazepam addiction treatment, helping men and women stop using and break free from this harrowing drug. Diazepam is used to treat muscle spasms, anxiety disorder, and seizures. It is also prescribed to control agitation brought on...

Michael Harper for redOrbit.com – Your Universe Online Ecosystems are complicated and tightly integrated systems. One small change to any part of the system can and will affect another part of the system further down the line. As humans, it’s sometimes easy to forget that we’re also a part of a larger ecosystem and that even the tiniest of actions can affect another living thing somewhere down the line. A recent study describes this sort of cause and effect chain reaction, finding...

Benzodiazepines affect immune system; Further scrutiny of safety warranted Commonly prescribed sleeping pills/sedatives may increase the risk of contracting pneumonia by as much as 50% and increase the risk of dying from it, suggests research published online in the journal Thorax. Benzodiazepines have a wide range of uses and are commonly prescribed for anxiety, epilepsy, muscle spasm, and insomnia. They are also frequently used in palliative care, as a sedative, and to help those with...

Lee Rannals for redOrbit.com – Your Universe Online Researchers are warning that taking sleeping pills may significantly increase your risk of developing dementia later in life. A Harvard University study found that those who used benzodiazepines were 50% more likely to succumb to the condition. During the study, researchers involved 1,063 men and women over the age of 65 for a period of 20 years in southwest France. At the onset of the study, none of the participants had...

Research: Benzodiazepine use and risk of dementia: prospective population based study Patients over the age of 65 who begin taking benzodiazepine (a popular drug used to treat anxiety and insomnia) are at an approximately 50% increased risk of developing dementia within 15 years compared to never-users, a study published today on bmj.com suggests. The authors say that "considering the extent to which benzodiazepines are prescribed and the number of potential adverse effects...

Drugs prescribed to treat anxiety, depression and insomnia may increase patients' risk of being involved in motor vehicle accidents, according to a recent study, published in the British Journal of Clinical Pharmacology. Based on the findings, the researchers suggested doctors should consider advising patients not to drive while taking these drugs. Psychotropic drugs affect the way the brain functions and can impair a driver's ability to control their vehicle. Research on the links between...

PHILADELPHIA, May 8, 2012 /PRNewswire/ -- The new prescription sleep aid Intermezzo (zolpidem tartrate) sublingual tablet CIV is the first and only prescription sleep aid approved by the U.S. Food and Drug Administration (FDA) for the treatment of insomnia when a middle-of-the-night awakening is followed by difficulty returning to sleep, and the patient has at least four hours of bedtime remaining before the planned time of waking. Intermezzo has gender-specific dosing (1.75 mg for...

POINT RICHMOND, Calif., April 5, 2012 /PRNewswire/ -- Transcept Pharmaceuticals, Inc. (Nasdaq: TSPT) announced today that Intermezzo® (zolpidem tartrate) sublingual tablet CIV is now available by prescription in 1.75 mg and 3.5 mg dosage strengths in retail pharmacies nationwide. Intermezzo is the first and only prescription sleep aid approved for middle-of-the-night dosing, and should only be taken once per night in bed, as needed, when a patient wakes up in the middle of...

STAMFORD, Conn., April 5, 2012 /PRNewswire/ -- Purdue Pharma L.P. announced today that Intermezzo(®) (zolpidem tartrate) sublingual tablet CIV is now available in 1.75 mg and 3.5 mg dosage strengths by prescription in retail pharmacies nationwide. Intermezzo is the first and only prescription sleep aid approved for middle-of-the-night dosing, and should only be taken once per night in bed, as needed, when a patient wakes up in the middle of the night and has difficulty returning to...

A new study finds that people who take certain commonly prescribed sleeping pills have a five-fold increased risk of death, even among those taking fewer than 18 doses a year. And these drugs are also linked to a significantly increased risk of cancer among those taking high doses, the study, published in the journal BMJ Open, shows. The study, analyzing 10,500 people who took a wide-range of sleeping pills including zolpidem, diazepam and tamazepam, found that the top third of sleeping...